Spun out of King’s College London, AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in overall funding.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.

The gastrointestinal disorder drug developer was co-founded by researchers from Stanford University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.